Reglan Linked to Serious Disorders.
April 7, 2009
Reglan, Alaven Pharmaceutical’s drug containing metoclopromide, got strong medicine from the Food and Drug Administration (FDA). The drug was approved for short term treatment, under 12 weeks, of gastroesophageal reflux disease (GERD) and other stomach and digestive tract ailments. However, many patients took Reglan for much longer than the recommended time frame of 12 weeks.
The FDA issued a “black box” warning for Reglan as well as generic forms of metoclopromide. A Black box warning is one of the strongest label requirements the FDA can place, and means that medical studies indicate that the drug carries a significant risk of serious or even life-threatening adverse effects.
Reglan has been linked to Tarkive Dyskinesia. Tardive dyskinesia is characterized by involuntary, repetitive movements of the extremities, or lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. Some mistake Tarkive Dyskinesia for Parkinson’s disease tremors. These symptoms are rarely reversible and there is no known treatment. However, in some patients, symptoms may lessen or resolve after metoclopramide treatment is stopped.
The S.E. Farris Law Firm has experience representing victims of dangerous drugs. If you or a loved one took Reglan or other metoclopromide containing drugs and are experiencing problems, contact The S.E. Farris Law Firm, at 314-252-9937. We will provide you with initial legal advice for free, and never charge anything unless we win for you.
“Male Enhancement” Product Gets Recalled!
March 20, 2009
Health Supplement company Bodee LLC announced that it is conducting a nationwide voluntary recall of Zencore Plus. Zencore Plus was advertised as a male enhancement product.
Bodee LLC is conducting this recall after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of Zencore Plus samples found the product contains benzamidenafil.
Benzamidenafil is likely to have the same pharmacological properties as sildenafil, tadalafil and vardenafil, which are the active ingredients of three FDA approved drugs for Erectile Dysfunction (ED).
The use of Zencore Plus by an unsuspecting user of organic nitrates may pose a life-threatening risk of sudden and profound drop of blood pressure due to potential interaction between benzamidenafil and organic nitrates.
The probability of this occurrence is unknown; therefore, it may cause a public health risk when used as a dietary supplement. Dietary supplements are typically sold with less oversight by the FDA than drugs, and items labeled as a “supplement” can’t promise to cure any disease or condition.
Zencore Plus is sold in health food stores and by mail order on internet nationwide. It is sold as a 2-capsule blister pack or as a 10-capsule blister pack in a retail box. The capsules were supplied by Hi-Tech Pharmaceuticals, Inc., Norcross, GA.
The S.E. Farris Law Firm represents victims of dangerous drugs and supplements. Visit us here at Farris Law .
The Supreme Court Gets it Right for Consumers!
March 5, 2009
Those who follow this blog, or pretty much anything I have ever written, know that I am not a huge fan of the decisions of the current U.S. Supreme Court. Over and over, this panel has ruled in favor of big business and the Haves of society, against consumers and the Have Nots. But even I try to give credit where it is due.
I wrote in these pages some time back about Phenergan, and the fight in the courts to make it impossible to sue a manufacturer of a dangerous and defective drug. Manufacturers argued that since the FDA (overworked and understaffed though they are) had regulated and approved certain drugs, no lawsuit could be filed for a drug that was FDA compliant.
Diane Levine used Phenergan for nausea. The drug was delivered by IV, under doctor supervision. Levine developed gangrene in her arm, and subsequently lost her arm near the IV site due to problems with the drug. When Wyeth, the manufacturer of Phenergan, refused to stand behind its dangerous product, Levine filed a lawsuit. A jury agreed that the drug was dangerous.
Wyeth argued that federal law forbade the lawsuit. This week, however, the United States Supreme Court disagreed. By doing so, they forced manufacturers to stand behind their products in court, rather than leaving those injured by defective drugs to bear the impact of the injury alone.
Score one for the consumer, and more importantly, score one for those hoping to make drugs safer for us all.